Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Nat Commun. 2023 Sep 13;14(1):5672. doi: 10.1038/s41467-023-41394-4.
Understanding the causal impact that clinical risk factors have on healthcare-related costs is critical to evaluate healthcare interventions. Here, we used a genetically-informed design, Mendelian Randomization (MR), to infer the causal impact of 15 risk factors on annual total healthcare costs. We calculated healthcare costs for 373,160 participants from the FinnGen Study and replicated our results in 323,774 individuals from the United Kingdom and Netherlands. Robust causal effects were observed for waist circumference (WC), adult body mass index, and systolic blood pressure, in which a standard deviation increase corresponded to 22.78% [95% CI: 18.75-26.95], 13.64% [10.26-17.12], and 13.08% [8.84-17.48] increased healthcare costs, respectively. A lack of causal effects was observed for certain clinically relevant biomarkers, such as albumin, C-reactive protein, and vitamin D. Our results indicated that increased WC is a major contributor to annual total healthcare costs and more attention may be given to WC screening, surveillance, and mitigation.
了解临床风险因素对医疗保健相关成本的因果影响对于评估医疗保健干预措施至关重要。在这里,我们使用一种基于遗传的设计方法——孟德尔随机化(MR)来推断 15 个风险因素对年度总医疗保健成本的因果影响。我们计算了来自 FinnGen 研究的 373160 名参与者的医疗保健成本,并在来自英国和荷兰的 323774 名个体中复制了我们的结果。腰围(WC)、成人体重指数和收缩压的稳健因果效应得到了观察,其中标准差增加对应于 22.78%[95%CI:18.75-26.95]、13.64%[10.26-17.12]和 13.08%[8.84-17.48]的医疗保健成本增加。某些临床相关生物标志物,如白蛋白、C 反应蛋白和维生素 D,则没有观察到因果效应。我们的结果表明,WC 的增加是年度总医疗保健成本的主要贡献因素,可能需要更多关注 WC 的筛查、监测和缓解。
Nat Commun. 2023-9-13
Arthritis Rheumatol. 2019-8-29
Physiol Rev. 2025-7-1
Eur Arch Psychiatry Clin Neurosci. 2024-8-27
Health Econ Policy Law. 2024-10
Lancet Reg Health West Pac. 2024-2-6
BMC Public Health. 2024-1-9
Circ Genom Precis Med. 2022-10